 |
|
|
| |
Efficacy of dolutegravir plus lamivudine in treatment-naïve people living with HIV without baseline drug-resistance testing available: 48-week results from the randomized D2ARLING study
|
| |
| |
E. Cordova, J. Hernandez Rendon, V. Mingrone, P. Martin, G. Arevalo Calderon, S. Seleme, J. Ballivian, N. Porteiro
IDEAA Foundation, Reasearch Department. Buenos Aires, Argentina
|
| |
|
|
|
|
|
